2024Frontiers in immunology15 : 1443665
A clinical protocol for a German birth cohort study of the Maturation of Immunity Against respiratory viral Infections (MIAI)
Hartmann C, Khan R, Schöning J, Richter M, Willers M, Pirr S, Heckmann J, Dirks J, Morbach H, Konrad M, Fries E, Winkler M, Büchel J, Seidenspinner S, Fischer J, Vollmuth C, Meinhardt M, Marissen J, Schmolke M, Haid S, Pietschmann T, Backes S, Dölken L, Löber U, Keil T, Heuschmann P, Wöckel A, Sagar, Ulas T, Forslund-Startceva S, Härtel C, Viemann D
2024Antimicrobial agents and chemotherapy68 (3) : e0121023
Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targets
Haid S, Matthaei A, Winkler M, Sake S, Gunesch A, Milke V, Köhler N, Rückert J, Vieyres G, Kühl D, Nguyen T, Göhl M, Lasswitz L, Zapatero-Belinchón F, Brogden G, Gerold G, Wiegmann B, Bilitewski U, Brown R, Brönstrup M, Schulz T, Pietschmann T
2024Nature communications15 (1) : 1173
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor
Sake S, Zhang X, Rajak M, Urbanek-Quaing M, Carpentier A, Gunesch A, Grethe C, Matthaei A, Rückert J, Galloux M, Larcher T, Le Goffic R, Hontonnou F, Chatterjee A, Johnson K, Morwood K, Rox K, Elgaher W, Huang J, Wetzke M, Hansen G, Fischer N, Eléouët J, Rameix-Welti M, Hirsch A, Herold E, Empting M, Lauber C, Schulz T, Krey T, Haid S, Pietschmann T
2023The Journal of hospital infection141 : 25-32
Virucidal activity of oral, hand, and surface disinfectants against respiratory syncytial virus
Meister T, Friesland M, Frericks N, Wetzke M, Haid S, Steinmann J, Todt D, Pietschmann T, Steinmann E
2023Angewandte Chemie (International ed. in English)62 (6) : e202214595
Persicamidines-Unprecedented Sesquarterpenoids with Potent Antiviral Bioactivity against Coronaviruses
Keller L, Oueis E, Kaur A, Safaei N, Kirsch S, Gunesch A, Haid S, Rand U, Čičin-Šain L, Fu C, Wink J, Pietschmann T, Müller R
2022Angewandte Chemie (International ed. in English)61 (52) : e202212946
Thiamyxins: Structure and Biosynthesis of Myxobacterial RNA-Virus Inhibitors
Haack P, Harmrolfs K, Bader C, Garcia R, Gunesch A, Haid S, Popoff A, Voltz A, Kim H, Bartenschlager R, Pietschmann T, Müller R
2022Antimicrobial agents and chemotherapy66 (12) : e0103222
Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle Stages
Sake S, Kosch C, Blockus S, Haid S, Gunesch A, Zhang X, Friesland M, Trummer S, Grethe C, Kühnel A, Rückert J, Duprex W, Huang J, Rameix-Welti M, Empting M, Fischer N, Hirsch A, Schulz T, Pietschmann T
2022Antimicrobial resistance and infection control11 (1) : 88
Target capture sequencing reveals a monoclonal outbreak of respiratory syncytial virus B infections among adult hematologic patients
Baier C, Huang J, Reumann K, Indenbirken D, Thol F, Koenecke C, Ebadi E, Heim A, Bange F, Haid S, Pietschmann T, Fischer N
2022Journal of virology96 (7) : e0199521
The Human Liver-Expressed Lectin CD302 Restricts Hepatitis C Virus Infection
Reinecke B, Frericks N, Lauber C, Dinkelborg K, Matthaei A, Vondran F, Behrendt P, Haid S, Brown R, Pietschmann T
2022BMC pulmonary medicine22 (1) : 88
IRIS: Infection with RespIratory Syncytial Virus in infants-a prospective observational cohort study
Wetzke M, Funken D, Lange M, Bejo L, Haid S, Monteiro J, Schütz K, Happle C, Schulz T, Seidenberg J, Pietschmann T, Hansen G